Skip to main content
. 2023 Nov 9;17:1294420. doi: 10.3389/fncel.2023.1294420

FIGURE 2.

FIGURE 2

Influence of obesity on neurodegenerative diseases. This figure illustrates the shared and distinctive effects of obesity on multiple sclerosis (MS), Alzheimer’s disease (AD), and Parkinson’s disease (PD), providing insights into the common pathways and disease-specific mechanisms contributing to neurodegeneration in these conditions. 3xTgAD, Triple-transgenic model of Alzheimer’s disease; Aβ, Amyloid-beta; APP, amyloid-beta precursor protein; BBB, blood brain barrier; DMTs, disease modifying treatments; CNS, Central Nervous System; FA, fatty acid; LepR, leptin receptor; PPAR, peroxisome proliferator-activated receptor; SN, substantia nigra, TH, tyrosine hydroxylase; VTA, ventral tegmental area.